Preparation and characterization of lung-targeting cefquinome-loaded PLGA microspheres

Abstract

We developed poly lactic-co-glycolic acid (PLGA) microspheres loaded with cefquinome and tested their effectiveness in a mouse model. The microspheres were prepared by optimizing several key parameters such as PLGA molecular weight, drug/polymer ratio, internal water volume and ethyl acetate. Drug loading efficiency, stability, in vitro release and tissue distribution in mouse were evaluated. The average particle size of the microspheres was 27.84 μm. The drug loading efficiency was 64.57%. The in vitro release of cefquinome from microspheres after 4 h was about 40% compared with over 90% for the drug alone. The concentration of cefquinome in lung reached 25 μg/g 0.25 h after injection, and kept at 10 μg/g 4 h after injection. However, the concentration of cefquinome was very low in other organs even 0.25 h after injection. In conclusion, Cefquinome-loaded PLGA microspheres are compatible as an effective lung-targeting drug delivery system and have a good sustained release efficacy.

Keywords

PLGA microspheres / cefquinome / lung-targeting / sustained release / size / mouse

References

[1] Yehia AM, Arafa RM, Abbas SS. Ratio Manipulating Spectrophotometry versus Chemometry as Stability Indicating Methods for Cefquinome Sulfate Determination[J]. Spectrochim. Acta A., 2015, 153: 231-240.

[2] Thomas E, Thomas V, Wilhelm C. Antibacterial Activity of Cefquinome Against Equine Bacterial Pathogens[J]. Vet. Microbiol., 2006, 115: 140-147.

[3] Harsha S, Chandramouli R, Rani S. Ofloxacin Targeting to Lungs by Way of Microspheres[J]. Int. J. Pharm., 2009, 380: 127-132.

[4] Yang F, Wu SG, Pan YF. Preparation and Characteristics of Erythromycin Microspheres for Lung Targeting[J]. Drug Dev. Ind. Pharm., 2009, 35(6): 639-645.

[5] Yan W, Bing G, Diane J. BurgessMicrospheres Prepared with PLGA Blends for Delivery of Dexamethasone for Implantable Medical Devices[J]. Pharm Res-Dordr., 2014, 31: 373-381.

[6] Patel M, Sunil KJ, Awesh K. Preparation and Characterization of Oxybenzone-Loaded Gelatin Microspheres for Enhancement of Sunscreening Ef?cacy[J]. Drug Deliv., 2006, 13: 323-330.

[7] Harsha S, Aldhubiab BE, Nair AB. Novel Drying Technology of Microsphere and Targeted Drug Delivery for Lungs[J]. Dry Technol., 2015, 33: 502-512.

[8] Shanthi NC, Dr GR, Mahato KA. Traditional and Emerging Applications of Microspheres: A Review[J]. Int. J. Pharm., 2010, 2(1): 675-681.

[9] Gupta R, Prajapati SK, Pattnaik S. Formulation and Evaluation of Novel Stomach Specific Floating Microspheres Bearing Famotidine for Treatment of Gastric Ulcer and Their Radiographic Study[J]. Asian Pac. J. Trop. Med., 2014, 4(9): 729-735.

[10] Saralidze K, Leo H. Koole. Polymeric Microspheres for Medical Applications[J]. Materials, 2010, 3: 3357-3564.

[11] Rajkumar K, Sainath GR, Saisowjanya P. Floating Microsheres: A Novel Approach in Drug Delivery Research[J]. J. Drug Deliv. Sci. Technol., 2012, 4: 1-17.

[12] Mathew ST, Devi GS, Prasanth VV. Suitability of Factorial Design in Determining the Processing Factors Affecting Entrapment Efficiency of Albumin Microspheres[J]. Int. J. Pharm., 2010, 3(5): 1172-1177.

[13] Zhang J, Shang Q, Zhai JH. Fabrication, Characterization, and controlled Release of Eprinomectin from Injectable Mesoporous PLGA Microspheres[J]. RSC Advance, 2015, 15(92): 75025-75032.

[14] Iwata M, Mcginity JW. Preparation of Multi-phase Microspheres of Poly (D, L-lactic acid) and Poly (D, L-lactic-co-glycolic acid) Containing a W/O Emulsion by A Multiple Emulsion Solvent Evaporation Technique[J]. J. Microencapsul., 1992, 9(2): 201-214.

[15] Huo DJ, Deng SH, Li LB. Studies on the Poly (lactic-co-glycolic) Microspheres of Cisplatin for Lung-targeting[J]. Int. J. Pharm., 2005, 289: 63-67.

[16] Yang Y, Gao Y, Mei X. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA Microspheres[J]. Pharm. Dev. technol., 2013, 18(5): 1169-1174.

[17] Fu X, Ping Q, Gao Y. Effects of Formulation Factors on Encapsulation Efficiency and Release Behaviour in Vitro of Huperzine A PLGA Microspheres[J]. J. Microencapsul., 2005, 22: 57-66.

[18] Bilati U, Allemann E, Doelker E. Poly(D, L-lactide-co-glycolide) Protein Loaded Nanoparticles Prepared by the Double Emulsion Method—processing and Formulation Issues for Enhanced Entrapment Efficiency[J]. J. Microencapsul., 2005, 22(2): 205-214.

[19] Freytag T, Dashevsky A, Tillman L. Improvement of the Encapsulation Efficiency of Oligonucleotide-containing Biodegradable Microspheres[J]. J. Control Release, 2000, 69(1): 197-207.

[20] Hao Z, Qu B, Wang Y. Preparation and Characterization of Lung-targeting Ceftiofur-loaded Gelatin Microspheres[J]. Drug Dev. Ind. Pharm., 2011, 37(12): 1422-1428.

[21] Freitas S, Merkle H, Gander B. Microencapsulation by Solvent Extraction /Evaporation: Reviewing the State of the Art of Microsphere Preparation Process Technology[J]. J. Control Release, 2005, 102: 313-332.

[22] Su Z, Sun F, Shi Y. Effects of Formulation Parameters on Encapsulation Efficiency and Release Behavior of Risperidone poly (D, L-lactideco-glycolide) Microsphere[J]. Chem. Pharma Bull., 2009, 57: 1251-1256.

[23] Kutscher HL, Chao P, Deshmukh M. Threshold Size for Optimal Passive Pulmonary Targeting and Retention of Rigid Microparticles in Mouse[J]. J. Control Release, 2010, 143: 31-37.